Novavax Inc. buy BTIG Research
Start price
20.01.26
/
50%
€7.35
Target price
20.01.27
€16.32
Performance (%)
-5.71%
Price
10.04.26
€6.93
Summary
This prediction is currently active. With a performance of -5.71%, the BUY prediction for Novavax Inc. by BTIG_Research is down slightly. This prediction currently runs until 20.01.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novavax Inc. | 3.603% | 3.603% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by BTIG_Research for this prediction
In the thread Novavax Inc. diskutieren
Novavax (NASDAQ:NVAX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $19.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat